Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis

BMC Cardiovascular Disorders

Volumn 12, Issue , 2012, Pages

  Wisløff, Torbjørn ^a,b   Selmer, Randi M ^c   Halvorsen, Sigrun ^d   Fretheim, Atle ^a,b   Norheim, Ole F ^e   Kristiansen, Ivar S ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN KNOWLEDGE CENTRE FOR THE HEALTH SERVICES   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GENERIC DRUG; THIAZIDE DIURETIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG CHOICE; DRUG COST; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; OUTCOME ASSESSMENT; PRIMARY PREVENTION; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DRUG COSTS; DRUGS, GENERIC; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PRIMARY PREVENTION;

EID: 84861193632     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-12-26     Document Type: Article

References (54)

1. World Health Organization The World Health Report 2002: reducing risks, promoting healthy life. Geneva 2002, World Health Organization.
2. Håheim LL, Fretheim A, Brørs O, Kjeldsen SE, Kristiansen IS, Madsen S, Njølstad I, Norheim OF, Ose L, Svilaas A, et al. Primærforebygging av hjerte- og karsykdom, med hovedvekt på medikamentelle tiltak 2008,
3. Williams B. Recent hypertension trials: implications and controversies. J Am Coll Cardiol 2005, 45:813-827. 10.1016/j.jacc.2004.10.069, 15766813.
4. Kaplan NM, Opie LH. Controversies in hypertension. Lancet 2006, 367:168-176. 10.1016/S0140-6736(06)67965-8, 16413880.
5. McCabe C, Claxton K, Culyer AJ. The NICE cost-effectiveness threshold: what it is and what that means. Pharmacoeconomics 2008, 26:733-744. 10.2165/00019053-200826090-00004, 18767894.
6. Wisløff T, Norheim OF, Halvorsen S, Selmer R, Kristiansen IS. Kostnader og leveårsgevinster ved medikamentell primærforebygging av hjertekarsykdom 2008,
7. Wisløff T, Selmer R, Halvorsen S, Kristiansen IS. Norwegian Cardiovascular Disease model (NorCaD). Oslo 2008,
8. Helseundersøkelsen i Nord-Trøndelag. , http://www.hunt.ntnu.no/index.php?side=pop/nt/voksne/fylke
9. Hjerte-, kar-, og slagregisteret - Helseregion vest. , http://www.uib.no/hks/
10. Ellekjaer H, Holmen J, Indredavik B, Terent A. Epidemiology of stroke in Innherred, Norway, 1994 to 1996. Incidence and 30-day case-fatality rate. Stroke 1997, 28:2180-2184. 10.1161/01.STR.28.11.2180, 9368561.
11. Daly C, Clemens F, Lopez Sendon JL, Tavazzi L, Boersma E, Danchin N, Delahaye F, Gitt A, Julian D, Mulcahy D, et al. Gender differences in the management and clinical outcome of stable angina. Circulation 2006, 113:490-498. 10.1161/CIRCULATIONAHA.105.561647, 16449728.
12. Hasdai D, Behar S, Wallentin L, Danchin N, Gitt AK, Boersma E, Fioretti PM, Simoons ML, Battler A. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J 2002, 23:1190-1201. 10.1053/euhj.2002.3193, 12127921.
13. Follath F. Causes of acute heart failure: Acute de novo verus decompensated chronic heart failure. Presentation at ESC congress 2005 Stockholm 2005,
14. Rosolova H, Cech J, Simon J, Spinar J, Jandova R, Widimsky S, Holubec L, Topolcan O. Short to long term mortality of patients hospitalised with heart failure in the Czech Republic--a report from the EuroHeart Failure Survey. Eur J Heart Fail 2005, 7:780-783. 10.1016/j.ejheart.2005.03.009, 16051521.
15. Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, Dietz R, Gavazzi A, Hobbs R, Korewicki J, et al. The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003, 24:442-463.
16. Fox KA, Goodman SG, Anderson FA, Granger CB, Moscucci M, Flather MD, Spencer F, Budaj A, Dabbous OH, Gore JM. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003, 24:1414-1424. 10.1016/S0195-668X(03)00315-4, 12909070.
17. Budaj A, Flasinska K, Gore JM, Anderson FA, Dabbous OH, Spencer FA, Goldberg RJ, Fox KA. Magnitude of and risk factors for in-hospital and postdischarge stroke in patients with acute coronary syndromes: findings from a Global Registry of Acute Coronary Events. Circulation 2005, 111:3242-3247. 10.1161/CIRCULATIONAHA.104.512806, 15956123.
18. Stenestrand U, Wallentin L. Årsrapport RIKS-HIA 2005 2006,
19. de Winter RJ, Windhausen F, Cornel JH, Dunselman PH, Janus CL, Bendermacher PE, Michels HR, Sanders GT, Tijssen JG, Verheugt FW. Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med 2005, 353:1095-1104. 10.1056/NEJMoa044259, 16162880.
20. Zijlstra F, Hoorntje JC, de Boer MJ, Reiffers S, Miedema K, Ottervanger JP, van'T Hof AW, Suryapranata H. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999, 341:1413-1419. 10.1056/NEJM199911043411901, 10547403.
21. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, Abildgaard U, Pedersen F, Madsen JK, Grande P, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003, 349:733-742. 10.1056/NEJMoa025142, 12930925.
22. Terent A. Trends in stroke incidence and 10-year survival in Soderhamn, Sweden, 1975-2001. Stroke 2003, 34:1353-1358. 10.1161/01.STR.0000074038.71700.1C, 12750535.
23. Kammersgaard LP, Jorgensen HS, Reith J, Nakayama H, Pedersen PM, Olsen TS. Short- and long-term prognosis for very old stroke patients. The Copenhagen Stroke Study. Age Ageing 2004, 33:149-154. 10.1093/ageing/afh052, 14960430.
24. The National Stroke Register in Sweden Analyserande rapport från Riks-Stroke 2005, The National Stroke Register in Sweden.
25. Madsen MM, Busk M, Sondergaard HM, Bottcher M, Mortensen LS, Andersen HR, Nielsen TT. Does diabetes mellitus abolish the beneficial effect of primary coronary angioplasty on long-term risk of reinfarction after acute ST-segment elevation myocardial infarction compared with fibrinolysis? (A DANAMI-2 substudy). Am J Cardiol 2005, 96:1469-1475. 10.1016/j.amjcard.2005.07.053, 16310424.
26. Dickstein K, Gleim GW, Snapinn S, James MK, Kjekshus J. The impact of morbid events on survival following hospitalization for complicated myocardial infarction. Eur J Heart Fail 2006, 8:74-80. 10.1016/j.ejheart.2005.04.010, 16081319.
27. Wiseth R, Gundersen T, Halvorsen S, Nordrehaug JE, Steigen T, Myhre KI. PCI in acute myocardial infarction. SMM-rapport 2002(5) 2002,
28. Kløw N-E, Rotevatn S, Steigen T, Vatne K, Kristiansen IS. Wisløff T Norderhaug IN: Forebygging av restenose i hjertets kransårer 2004, 3089712, 21483405.
29. Nordmann AJ, Briel M, Bucher HC. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J 2006, 27:2784-2814. 10.1093/eurheartj/ehl282, 17020889.
30. van Wijk I, Kappelle LJ, Van Gijn J, Koudstaal PJ, Franke CL, Vermeulen M, Gorter JW, Algra A. Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. Lancet 2005, 365:2098-2104. 10.1016/S0140-6736(05)66734-7, 15964446.
31. Statistics Norway. , http://www.ssb.no/emner/03/01/10/dodsarsak/
32. Loh E, Sutton MS, Wun CC, Rouleau JL, Flaker GC, Gottlieb SS, Lamas GA, Moye LA, Goldhaber SZ, Pfeffer MA. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med 1997, 336:251-257. 10.1056/NEJM199701233360403, 8995087.
33. Dries DL, Rosenberg YD, Waclawiw MA, Domanski MJ. Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. J Am Coll Cardiol 1997, 29:1074-1080. 10.1016/S0735-1097(97)00019-3, 9120162.
34. Mosterd A, Cost B, Hoes AW, de Bruijne MC, Deckers JW, Hofman A, Grobbee DE. The prognosis of heart failure in the general population: The Rotterdam Study. Eur Heart J 2001, 22:1318-1327. 10.1053/euhj.2000.2533, 11465964.
35. Touze E, Varenne O, Chatellier G, Peyrard S, Rothwell PM, Mas JL. Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis. Stroke 2005, 36:2748-2755. 10.1161/01.STR.0000190118.02275.33, 16254218.
36. Hillen T, Coshall C, Tilling K, Rudd AG, McGovern R, Wolfe CD. Cause of stroke recurrence is multifactorial: patterns, risk factors, and outcomes of stroke recurrence in the South London Stroke Register. Stroke 2003, 34:1457-1463. 10.1161/01.STR.0000072985.24967.7F, 12750544.
37. Caro JJ, Migliaccio-Walle K, Ishak KJ, Proskorovsky I, O'Brien JA. The time course of subsequent hospitalizations and associated costs in survivors of an ischemic stroke in Canada. BMC Health Serv Res 2006, 6:99. 10.1186/1472-6963-6-99, 1564006, 16907982.
38. Wright JT, Dunn JK, Cutler JA, Davis BR, Cushman WC, Ford CE, Haywood LJ, Leenen FH, Margolis KL, Papademetriou V, et al. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA 2005, 293:1595-1608. 10.1001/jama.293.13.1595, 15811979.
39. Gaziano TA, Opie LH, Weinstein MC. Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet 2006, 368:679-686. 10.1016/S0140-6736(06)69252-0, 2365896, 16920473.
40. Murray CJL, Lauer JA, Hutubessy RCW, Niessen L, Tomijima N, Rodgers A, Lawes CMM, Evans DB. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: A global and regional analysis on reduction of cardiovascular-disease risk. Lancet 2003, 361(9359):717-725. Date of Publication: 01 MAR 2003, 10.1016/S0140-6736(03)12655-4, 12620735.
41. Fastlegetariffen - Normaltariff 2008,
42. Normaltariff for privat spesialistpraksis 2008,
43. ISF 2005. , http://drgforum.no/system/files/downloads/Informasjonshefte_ISF_2005.pdf
44. Felleskatalogen. , http://www.felleskatalogen.no
45. Briggs AH, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation 2006, Oxford University Press.
46. Critchfield GC, Willard KE. Probabilistic analysis of decision trees using Monte Carlo simulation. Med Decis Making 1986, 6:85-92. 10.1177/0272989X8600600205, 3702625.
47. Sælensminde K. Helseeffekter i samfunnsøkonomiske analyser 2007,
48. Claxton K, Paulden M, Gravelle H, Brouwer W, Culyer AJ. Discounting and decision making in the economic evaluation of health-care technologies. Health Econ 2011, 20:2-15. 10.1002/hec.1612, 21154521.
49. Nord E. Discounting future health benefits: the poverty of consistency arguments. Health Econ 2011, 20:16-26. 10.1002/hec.1687, 21154522.
50. Clinical Guideline 127 Hypertension - The clinical management of primary hypertension in adults. London, UK 2011, Clinical Guideline 127.
51. Lindholm LH, et al. Moderately elevated blood pressure 2004,
52. Chen N, Zhou M, Yang M, Guo J, Zhu C, Yang J, Wang Y, Yang X, He L. Calcium channel blockers versus other classes of drugs for hypertension. Cochrane Database Syst Rev 2010, CD003654.
53. Drummond MF, Sculpher M, Torrance GW, O'Brien BJ, Stoddard GL. Methods for the economic evaluation of health care programmes; 2005,
54. Kjeldsen SE, Jamerson KA, Bakris GL, Pitt B, Dahlof B, Velazquez EJ, Gupte J, Staikos L, Hua TA, Shi V, et al. Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: the ACCOMPLISH study. Blood Press 2008, 17:7-17. 10.1080/08037050801972857, 18568687.